B Cell Precursor Acute Lymphoblastic Leukemia
2 clinical trials · Condition
◉ Watch B Cell Precursor Acute Lymphoblastic Leukemia
| Record | Firm | Date |
|---|---|---|
| A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL (NCT04521231) | Amgen | 2021-01-04 |
Track B Cell Precursor Acute Lymphoblastic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.